Q2 2022 NovaBay Pharmaceuticals Inc Earnings Call Transcript
Welcome to the NovaBay Pharmaceuticals second-quarter 2022 financial results conference call. (Operator Instructions)
As a reminder, this conference is being recorded. I'd like to turn the conference over to Jody Cain. Please go ahead.
This is Jody Cain with LHA. Thank you for participating in today's call. Joining me from NovaBay are Justin Hall, Chief Executive Officer and General Counsel; Andy Jones, Chief Financial Officer; and Kim Shartsis, the company's Vice President of Commercial.
I'd like to remind listeners that comments made during this call by management will include forward-looking statements within the meaning of federal securities laws. These forward-looking statements involve risks and uncertainties that could cause the actual results to be materially different from any anticipated results.
In particular, there is uncertainty about circumstances beyond the company's control that impacts the broader economy such as the COVID-19 pandemic and the conflict between Russia and Ukraine. This means that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
